vs

Side-by-side financial comparison of 1stdibs.com, Inc. (DIBS) and ENANTA PHARMACEUTICALS INC (ENTA). Click either name above to swap in a different company.

1stdibs.com, Inc. is the larger business by last-quarter revenue ($23.0M vs $18.6M, roughly 1.2× ENANTA PHARMACEUTICALS INC). 1stdibs.com, Inc. runs the higher net margin — -4.5% vs -64.1%, a 59.6% gap on every dollar of revenue. On growth, ENANTA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.8% vs 0.9%). 1stdibs.com, Inc. produced more free cash flow last quarter ($3.6M vs $-11.8M). Over the past eight quarters, ENANTA PHARMACEUTICALS INC's revenue compounded faster (4.5% CAGR vs 2.0%).

1stdibs.com, Inc. is an American e-commerce company. It has an online marketplace, which sells luxury items such as high-end furniture for interior design, fine art and jewelry. The company has been recognized for "pushing the antiques business into the 21st century." Originally, founded in Paris, it is headquartered in New York City.

Enanta Pharmaceuticals Inc is a clinical-stage biotechnology company that develops innovative antiviral therapies for infectious diseases including hepatitis B virus, respiratory syncytial virus (RSV), and SARS-CoV-2. It operates primarily in the U.S. and global markets, partnering with pharmaceutical firms to advance its small molecule drug candidate pipeline for patients with unmet medical needs.

DIBS vs ENTA — Head-to-Head

Bigger by revenue
DIBS
DIBS
1.2× larger
DIBS
$23.0M
$18.6M
ENTA
Growing faster (revenue YoY)
ENTA
ENTA
+8.9% gap
ENTA
9.8%
0.9%
DIBS
Higher net margin
DIBS
DIBS
59.6% more per $
DIBS
-4.5%
-64.1%
ENTA
More free cash flow
DIBS
DIBS
$15.5M more FCF
DIBS
$3.6M
$-11.8M
ENTA
Faster 2-yr revenue CAGR
ENTA
ENTA
Annualised
ENTA
4.5%
2.0%
DIBS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
DIBS
DIBS
ENTA
ENTA
Revenue
$23.0M
$18.6M
Net Profit
$-1.0M
$-11.9M
Gross Margin
73.5%
Operating Margin
-10.1%
-60.5%
Net Margin
-4.5%
-64.1%
Revenue YoY
0.9%
9.8%
Net Profit YoY
80.0%
46.4%
EPS (diluted)
$-0.02
$-0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DIBS
DIBS
ENTA
ENTA
Q4 25
$23.0M
$18.6M
Q3 25
$22.0M
$15.1M
Q2 25
$22.1M
$18.3M
Q1 25
$22.5M
$14.9M
Q4 24
$22.8M
$17.0M
Q3 24
$21.2M
$14.6M
Q2 24
$22.2M
$18.0M
Q1 24
$22.1M
$17.1M
Net Profit
DIBS
DIBS
ENTA
ENTA
Q4 25
$-1.0M
$-11.9M
Q3 25
$-3.5M
$-18.7M
Q2 25
$-4.3M
$-18.3M
Q1 25
$-4.8M
$-22.6M
Q4 24
$-5.2M
$-22.3M
Q3 24
$-5.7M
$-28.8M
Q2 24
$-4.4M
$-22.7M
Q1 24
$-3.3M
$-31.2M
Gross Margin
DIBS
DIBS
ENTA
ENTA
Q4 25
73.5%
Q3 25
74.3%
Q2 25
71.8%
Q1 25
72.4%
Q4 24
72.3%
Q3 24
71.0%
Q2 24
71.7%
Q1 24
72.5%
Operating Margin
DIBS
DIBS
ENTA
ENTA
Q4 25
-10.1%
-60.5%
Q3 25
-21.3%
-121.6%
Q2 25
-25.8%
-103.2%
Q1 25
-27.7%
-164.3%
Q4 24
-30.6%
-138.8%
Q3 24
-34.9%
-204.4%
Q2 24
-29.2%
-134.6%
Q1 24
-24.3%
-192.1%
Net Margin
DIBS
DIBS
ENTA
ENTA
Q4 25
-4.5%
-64.1%
Q3 25
-16.0%
-123.6%
Q2 25
-19.5%
-99.7%
Q1 25
-21.3%
-151.7%
Q4 24
-22.9%
-131.4%
Q3 24
-26.8%
-197.3%
Q2 24
-20.0%
-126.1%
Q1 24
-15.0%
-182.7%
EPS (diluted)
DIBS
DIBS
ENTA
ENTA
Q4 25
$-0.02
$-0.42
Q3 25
$-0.10
$-0.88
Q2 25
$-0.12
$-0.85
Q1 25
$-0.14
$-1.06
Q4 24
$-0.14
$-1.05
Q3 24
$-0.15
$-1.36
Q2 24
$-0.12
$-1.07
Q1 24
$-0.08
$-1.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DIBS
DIBS
ENTA
ENTA
Cash + ST InvestmentsLiquidity on hand
$22.9M
$37.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$93.6M
$126.6M
Total Assets
$132.1M
$329.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DIBS
DIBS
ENTA
ENTA
Q4 25
$22.9M
$37.4M
Q3 25
$19.9M
$32.3M
Q2 25
$22.4M
$44.8M
Q1 25
$20.3M
$60.2M
Q4 24
$26.0M
$84.3M
Q3 24
$22.0M
$37.2M
Q2 24
$23.8M
$35.8M
Q1 24
$33.7M
$63.5M
Stockholders' Equity
DIBS
DIBS
ENTA
ENTA
Q4 25
$93.6M
$126.6M
Q3 25
$94.0M
$64.7M
Q2 25
$94.9M
$79.3M
Q1 25
$96.2M
$93.5M
Q4 24
$99.3M
$111.8M
Q3 24
$107.2M
$128.8M
Q2 24
$110.4M
$148.9M
Q1 24
$131.0M
$166.1M
Total Assets
DIBS
DIBS
ENTA
ENTA
Q4 25
$132.1M
$329.5M
Q3 25
$135.2M
$280.7M
Q2 25
$138.6M
$301.0M
Q1 25
$142.5M
$323.0M
Q4 24
$145.8M
$348.6M
Q3 24
$154.4M
$376.7M
Q2 24
$157.6M
$398.8M
Q1 24
$179.5M
$413.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DIBS
DIBS
ENTA
ENTA
Operating Cash FlowLast quarter
$4.3M
$-11.7M
Free Cash FlowOCF − Capex
$3.6M
$-11.8M
FCF MarginFCF / Revenue
15.7%
-63.6%
Capex IntensityCapex / Revenue
2.9%
0.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-3.2M
$-18.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DIBS
DIBS
ENTA
ENTA
Q4 25
$4.3M
$-11.7M
Q3 25
$-1.5M
$-6.5M
Q2 25
$-5.1M
$17.5M
Q1 25
$-96.0K
$-13.5M
Q4 24
$2.8M
$-16.8M
Q3 24
$-3.0K
$-10.4M
Q2 24
$-2.6M
$-14.8M
Q1 24
$-3.1M
$-28.6M
Free Cash Flow
DIBS
DIBS
ENTA
ENTA
Q4 25
$3.6M
$-11.8M
Q3 25
$-1.5M
$-7.9M
Q2 25
$-5.2M
$17.4M
Q1 25
$-143.0K
$-16.0M
Q4 24
$1.5M
$-25.5M
Q3 24
$-44.0K
$-19.4M
Q2 24
$-3.0M
$-21.3M
Q1 24
$-3.3M
$-30.3M
FCF Margin
DIBS
DIBS
ENTA
ENTA
Q4 25
15.7%
-63.6%
Q3 25
-6.8%
-52.5%
Q2 25
-23.4%
94.7%
Q1 25
-0.6%
-107.4%
Q4 24
6.5%
-150.6%
Q3 24
-0.2%
-132.5%
Q2 24
-13.5%
-118.6%
Q1 24
-14.8%
-177.5%
Capex Intensity
DIBS
DIBS
ENTA
ENTA
Q4 25
2.9%
0.8%
Q3 25
0.1%
9.6%
Q2 25
0.2%
0.8%
Q1 25
0.2%
17.0%
Q4 24
5.8%
51.6%
Q3 24
0.2%
61.3%
Q2 24
1.6%
36.4%
Q1 24
0.9%
9.8%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons